Form D · Pharmaceuticals
EXELA HOLDINGS INC
Lenoir, NC · CIK 0001406124
Offering snapshot reported Sep 15, 2021 · SEC filing
- Reported sold
- $26M Offering amount: $26M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2021 | Initial | $26,000,000 | No comparison | Not reported | SEC filing |
| Aug 24, 2015 | Initial | $419,828 | No comparison | 1 | SEC filing |
| Jun 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-413454
Source: Form D, filed Sep 15, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Murali Krishna Reddy Adala | Director |
| Thomas Baruch | Director |
| David Collier | Director |
| Robert Funsten | Director |
| Padmavathi Koneru | Executive |
| Phanesh Koneru | Director, Executive |
| Frank Wright | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1245 Blowing Rock Blvd.
Lenoir, NC, 28645
Lenoir, NC, 28645